ImmunoGen Stock Price (NASDAQ:IMGN)

Add to My Stocks
$8.85 $0.01 (0.11%) IMGN stock closing price Aug 16, 2018 (Closing)
Prev Close* : $8.86
Market Cap:
$1.32B
Day Low: $8.63
52 Week Low: $4.80
Open: $8.95
Volume: -
Day High: $8.95
52 Week High: $13.41
Dividend:
0.00

Latest Stock Market News

Latest Articles

ImmunoGen News - From Partners

The Brian Bolan Show!   by Zacks on Jun 14, 2018

IMGN Stockcharts

View IMGN PE ratio, PS ratio stocks charts and compare with peers.
IMGN Chart
Note: Compare ImmunoGen stock price history with the index and industry peers.

ImmunoGen Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
15.44
PB ratio (
price to book ratio
)
-23.83

ImmunoGen Returns

ROE
(return on equity)
-

ImmunoGen Financial Ratios

Asset Turnover
-
Receivables Turnover
-
Debt to Equity
-
Dividend Yield
0%

IMGN Industry Peers

Company Price Change (%)
Arrowhead Pharma (ARWR)14.330.42 (2.85%)
Corcept Therapeutics (CORT)12.50 (0%)
Takeda Pharma (TKPYY)20.850.57 (2.81%)
Amgen (AMGN)196.441.18 (0.6%)
Seattle Genetics (SGEN)74.210.31 (0.42%)
Novartis (NVS)82.190.36 (0.44%)
Sanofi (SNY)41.250.85 (2.1%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
CORREVIO PHARMA (CORV)5.080.52 (11.4%)
La Jolla Pharma (LJPC)22.411.87 (9.1%)
Aratana Therapeutics (PETX)5.250.27 (5.42%)
ArQule (ARQL)6.280.31 (5.19%)
AcelRx Pharma (ACRX)3.10.15 (5.08%)
Galectin Therapeutics (GALT)3.850.17 (4.62%)
Synergy Pharma (SGYP)1.820.07 (4%)
Top gainers from Medical-Drugs industry
* As of Aug 17, 2018
CompanyPriceChange (%)
Adamis Pharma (ADMP)2.8250.58 (17.06%)
MELINTA THERAPT (MLNT)4.20.3 (6.67%)
Tetraphase Pharmaceuticals (TTPH)2.950.14 (4.53%)
ChemoCentryx (CCXI)10.950.46 (4.03%)
Pacira Pharma (PCRX)46.21.75 (3.65%)
Arrowhead Pharma (ARWR)14.330.42 (2.85%)
CASI Pharma (CASI)7.390.21 (2.76%)
Top losers from Medical-Drugs industry
* As of Aug 17, 2018

ImmunoGen, Inc. Stock News - Partner Headlines

ImmunoGen Financial Statements

income statement20172016201520142013
Net Sales or Revenues115.44M-18.02M48.3M30.06M
Net Income-96.01M--33.22M13.63M3.81M
Total Operating Expense174.42M046.24M34.51M26.3M
View ImmunoGen income statement
balance sheet20172016201520142013
Total Assets294.67M198.86M251.58M128.54M202.52M
Total Liabilities312.57M351.71M268.26M51.07M72.48M
Shareholders Equity-17.89M-152.85M-16.68M77.47M130.03M
View ImmunoGen balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities77.58M--9.55M-37.77M-25.05M
Net Cash from (used by) Operating Activities7.64M--65.49M-34.38M-21.62M
Increase (Decrease) in Prop Plant And Equipment-1.11M--5.12M-2.59M-2.29M
View ImmunoGen cash flow statement

ImmunoGen Stock Message Board

As of last trading day, ImmunoGen stock price was $8.85. ImmunoGen market capitalization is $1.32B and it represents the total market value of IMGN stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing ImmunoGen stock analysis.

For recognizing and analyzing the real performance of ImmunoGen stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume of shares traded stood at 1,564,368 on the last trading day, as is evident from ImmunoGen stock chart, and IMGN stock quote data. ImmunoGen paid 0.00 stock dividends to its shareholders during last quarter. To check the historical stock price movement, all time high, and all time low of IMGN, view ImmunoGen stock price history.